Market Research Reports
This report provides insights into biomarkers being explored in interventional, active oncology trials in the US. The database platform helps track biomarkers used in trials across therapy classes, cancer indications, and sponsors. It includes >2,500 captured and curated active, oncology clinical trials in the US. It is a rigorous assessment of industry trends with detailed segmentation across publications, grants, clinical trials, and startup funding activities. The data extracted from each trial includes biomarkers, biomarker functions, therapy classes, trial phases, cancer indications, start and completion dates, enrollment, sponsors, and therapies.
This biomarker data enables pharma, diagnostics, and research tools companies to identify emerging biomarkers of interest, assess competitive landscape, and prioritize biomarker developments.
The file delivered is a Tableau Workbook with 10 tabs – requires downloading the free version of the Tableau Reader at https://www.tableau.com/reader.
Our “Warehousing Clinical & Genomics Biomedical Data – A Challenges & Needs Analysis Report” analyzes the observations and learnings across the complex components of biomedical data warehousing, querying, and collaboration to further clinical applications via population studies, data querying, and validation of research findings.
Twenty-one (21) end user interviews from eighteen (18) medical research organizations provided insights into medical industry and end users’ unmet biomedical (clinical & genomics) data needs and challenges.
This new, qualitative report provides an in-depth analysis across the complex, multi-step clinical genomics data process (which includes genomic data generation, data flow, and data warehousing), clinical genomics data solution providers, market trends, technologies impacting clinical genomics applications development, clinical genomics adoption challenges, and a detailed challenge & needs analysis as identified in discussions with clinical end users.
This 280-page Clinical Genomics Report consists of 13 Figures, 95 Tables, 14 comprehensive Medical Organization Profiles, and 20 comprehensive Company Profiles
$1,750.00 - $7,000.00
This report provides insights into the transformational microbiome landscape. It is a rigorous assessment of industry trends with detailed segmentation across publications, grants, clinical trials, and startup funding activities. The report is based on real world evidence that will drive actionable insights. Unearth data driven intelligence to power marketing campaigns, fundraising, investor pitches, and business/corporate development activities. Tap into premium data sources that leverage NLP and relational search paradigm to uncover relevant data points, all in one package.
Our “Clinical NGS Workflow Report” details the observations and learning across the complex, multi-step informatics aspects following clinical NGS sample preparation and sequencing, and which includes data analysis, knowledge extraction, and clinical reporting of actionable findings.
Market trends, including listing of major initiatives, merger and acquisitions, and a summary of patents are detailed within the report, while also highlighted are clinical customer/end-users’ unmet interpretation and knowledge extraction needs and challenges, and genetic testing lab preferences. Finally, an extensive comparison of solution providers in the SaaS and PaaS sector for the analysis and interpretation of clinical NGS data is included.
Fiona Nielsen, Founder & CEO
This NGS Process Report has a lot of very valuable data to gain an overview of the field of NGS companies in kits and analytics. The summarized user interviews are excellent. enlightenbio succeeded in encapsulating the current “NGS space” status quo and summarizing the observed challenges and market trends. This report is highly recommended for commercial companies and investors in the space.
Healthcare Market Research
We monitor global and regional market trends, segments, and developments in the medical devices, life sciences, healthcare information technology, and clinical diagnostics space.
Our future-focused outlook makes us a resourceful and exciting alternative to traditional market research companies. Our comprehensive knowledge of the market we live and breathe is invaluable to our partnerships and to the potential for our customers.
Building on our initial success and previous experiences - microarray and next-generation sequence data analysis, toxicogenomics, solutions for sequence data management, analysis, and interpretation, drug discovery, and biochemistry - we continuously monitor worldwide market trends in healthcare information technology, life sciences, genomics, clinical diagnostics, and medical devices space to expand our critical service offerings. Combined with our extensive global network, we can identify target market pain points and unmet needs, perform detailed market and product research, perform horizontal and vertical ecosystem or competitive analyses, and more.
Competitive/ecosystem analysis & custom market research
Building on our initial success and previous experiences - microarray and next-generation sequence data analysis, toxicogenomics, solutions for sequence data management, analysis, and interpretation, drug discovery, and biochemistry - we continuously monitor worldwide market trends in healthcare information technology, genomics, clinical diagnostics, genetics, and precision medicine.
Join our growing follower base across academia, pharma, clinical diagnostics, and innovative commercial solution provider and sign up for our Monthly Newsletter.
A compilation of the newsletter can be found on our Industry News page which we are updating and adding to on a regular basis.